We characterized all transcripts whose splicing relies on RNF113A and also established a link between RNF113A and MCL-1 stabilization, with important consequences for the treatment of lung cancer cells showing some acquired resistance to BCL-2 inhibitors. This evidence concerns the gene BCL2 and lung cancer.